Select your language/region

Q-linea strengthens commercial leadership team in Europe

Q-linea strengthens commercial leadership team in Europe

Q-linea AB (publ) (OMX: QLINEA) today announces that Franco Pellegrini has been appointed as Sales Director for Southern Europe at Q-linea.

In line with Q-linea’s strategy to extend the commercial footprint across Europe and the formation of an Italian legal entity Q-linea S.r.l., Franco Pellegrini has joined the company by July 1st to lead the local organisation and the collaboration with distribution partners in France, Iberia and Belgium.

“It’s great to see Franco coming on board and with him we will gain a lot of experience and expertise in the clinical end markets across the region. He had senior roles in the Microbiology division of Thermo Fisher Scientific over the last 13 years and a deep understanding of AST applications and customer needs. We have seen the evaluation and tender activities increasing over the last months and with the recent signing of our distribution partnership with Eurobio Scientific in France, I am convinced he will be a great support for the success of ASTar® and Q-linea” says Thomas Fritz, CCO at Q-linea.

Franco Pellegrini added: “I have been working with ASTar in my previous role and from day one I saw the great capabilities of the system and how it could make a change for treatment and outcome for critically ill patients so I definitely wanted to be part of this within Q-linea.”

About ASTar Instrument and ASTar BC G- Kit
ASTar Instrument and ASTar BC G- Kit already deliver the broadest answer regarding the combination of the number of antibiotics and the number of double dilution steps of each antibiotic, in a single analysis for gram-negative bacteria. The test enables the analysis of gram-negative bacteria, including difficult-to-grow so-called fastidious bacteria, which satisfies the need for rapid and comprehensive results to support optimal treatment decisions.

ASTar Instrument and ASTar BC G- Kit are CE-marked but not FDA 510(k)-cleared and not available for sale in the United States.